[Glyciram as an enhancer of the effectiveness of chemotherapy and surgery in the treatment of experimental neoplasms].

Abstract	Glycyrramum was shown to potentiate the antitumor and antimetastatic effects of cyclophosphamide treatment in mice and rats with transplantable tumors. It also decreased its myelotoxicity. After primary Lewis lung carcinoma was removed glycyrramum treatment significantly inhibited metastacizing processes in mice.
Authors	T G Razina, E P Zueva, E N Amosova, V V Zhdanov
Journal	Voprosy onkologii (Vopr Onkol) Vol. 45 Issue 5 Pg. 554-6 ( 1999) ISSN: 0507-3758 [Print] Russia (Federation)
Vernacular Title	Glitsiram kak sredstvo povysheniia èffektivnosti khimioterapii i khirurgicheskogo metoda lecheniia èksperimental'nykh opukholeĭ.
PMID	10629717 (Publication Type: English Abstract, Journal Article)
Chemical References	Antineoplastic Agents Antineoplastic Agents, Alkylating Cyclophosphamide Glycyrrhetinic Acid
Topics	Animals Antineoplastic Agents (pharmacology) Antineoplastic Agents, Alkylating (pharmacology) Carcinoma, Lewis Lung (drug therapy, prevention & control, secondary, surgery) Cyclophosphamide (pharmacology) Drug Synergism Female Glycyrrhetinic Acid (pharmacology) Mice Mice, Inbred C57BL Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!